Relieving Pain. Restoring Lives.

Our approach

Keimon Medical has developed an innovative solution that quickly and cost-effectively delivers transformational, long-term pain relief through a unique outpatient device-based treatment.

Our minimally invasive, high-throughput, office-based approach is designed for repeat treatment when pain returns and supersedes the current state of the art by better effect, better adverse event profile and lower cost.

We are currently advancing a pipeline of candidate targets in multiple pain conditions to bring much needed pain relief where it is needed the most.

About us

Keimon Medical Ltd is a Dublin based early-stage med tech company. Drawing upon research conducted at one of Europe’s premier research centers specializing in headache and facial pain, we have meticulously developed a transformative method for pain treatment applicable to a diverse range of pain conditions.

Team

Our team is commited to scientific excellence and a genuine passion for delivering innovative therapies to those in need.

We possess a profound understanding of pain disorders and their underlying mechanisms, offering an unprecedented opportunity for significant breakthroughs in pain treatment.

Fergus O’Dea

Co-founder & CEO

15+ years’ life science and medtech experience.
Strong early-stage start-up leadership, proven investor engagement, and a broad international network.

Daniel Bratbak

Co-founder & CSO

Assoc. Professor & Neurosurgeon
Serial medtech entrepreneur with a proven track record, including a successful exit

Stephen Sheridan

Co-founder, CTO

20 years’ industry experience leading early stage invasive medical device development and extensive US & EU regulatory expertise.

Board

Joey Mason

Chair

30+ years of life science experience.
Currently with Claret Capital Partners & Sofinnova Partners

Don Deyo

Director

Former VP R&D Medtronic
8 first-in-human medtech innovations
9 years in neuromodulation (Medtronic)

Medical Advisors

Supported by globally recognised leaders in chronic pain and a world-renowned research center

Prof. David W. Dodick

Mayo Clinic, Arizona, USA

Past-President, International Headache Society
& American Headache Society
Founder, Mayo Clinic Headache Program
900+ peer-reviewed publications

Prof. Manjit Matharu

National Hospital for Neurology, London, UK

Clinical & Academic Lead, Headache Group
UCL Queen Square & National Hospital for Neurology
Global expert in headache and facial pain disorders

Prof. Erling Tronvik

NorHead/ NTNU, Trondheim, Norway

Co-founder Keimon
Sientific Director, Norhead
Professor, NTNU & St.Olavs Hospital
Leader in transatlantic headache research

Assoc. Prof. Tore Wergeland

NorHead/ NTNU, Trondheim, Norway

Co-founder Keimon
Assosciate Professor, NTNU
Headache specialist and researcher in interventional headache trials

Contact

6th Floor, 2 Grand Canal Square, Dublin 2, D02 A342, Ireland
E-mail: contact@keimonmedical.com

We have been supported by: